Background: Chagas disease, caused by the protozoan parasite Trypanosoma cruzi,
| INTRODUCTION
Infection with the protozoan parasite Trypanosoma cruzi causes Chagas disease in humans and animals across the Americas and is the leading cause of infectious myocarditis in humans worldwide. 1 Trypanosoma cruzi infection can occur by vector-mediated transmission by triatomine insects after the introduction of infected bug feces into the bite site or mucous membrane, through the ingestion of infected bugs or their feces, or through congenital transmission. 2, 3 In both dogs and humans, clinical outcome is variable, ranging from sudden death to chronic heart disease but also including asymptomatic infections. In some ecological settings, dogs can be sentinels of human disease risk. 3, 4 Chagas disease is increasingly recognized in the southern United States, where the parasite is maintained among diverse wildlife in sylvatic transmission cycles. 2, 5 The seroprevalence of T. cruzi in dogs is particularly high in the state of Texas, with seroprevalence estimates of 6%-13% in shelter dogs across the state, 6%-18% in government working dogs along the TexasMexico border, and seroprevalence exceeding 50% in some multi-dog kennel environments with triatomine infestations. [6] [7] [8] Seropositive dogs occur in Louisiana, Oklahoma, Tennessee, Georgia, and Virginia. [9] [10] [11] [12] [13] [14] [15] Clinical presentation of Chagas heart disease varies widely depending on the extent of myocardial damage that results in a combination of arrhythmias, conduction abnormalities, heart enlargement, and heart failure. 16, 17 There are 4 recognized pathogenic mechanisms for the development of Chagas heart disease in humans: (1) parasite-induced damage to the cardiac tissue; (2) cardiac dysautonomia, microvascular circulation disturbances; (3) immune-mediated myocardial injury; and (4) neurogenic disorders. 18, 19 In the limited experimental models of Chagas disease in dogs, acute clinical signs were detected between 14 and 21 days postexposure. 20 Acute signs are nonspecific and include lethargy, generalized lymphadenopathy, pale mucous membrane, slow capillary refill time, ascites, weak pulse, enlarged liver, enlarged spleen, and sudden death. 20 During this stage, arrhythmia and conduction abnormalities can be detected in infected dogs. 18, 21 Both human and dogs can then enter an indeterminate period where clinical signs are not evident. 18, 21 Chronic Chagas disease in dogs is associated with ventricular arrhythmias, predominantly premature contractions, which can be multiform and progress to ventricular tachycardia. 21 As chronic Chagas disease progresses, the dogs could develop myocardial dysfunction and heart failure. 18, [21] [22] [23] Experimental treatments, such as benznidazole, in dogs can cause a temporary reduction in parasite load, but the treatment does not prevent myocardial lesions or dysfunction. 24, 25 In the United States, there are currently no vaccinations or approved antiparasitic treatments for T. cruzi infections in dogs, and infected dogs are typically treated symptomatically.
Limited studies have been conducted in dogs naturally infected with T. cruzi, and a better understanding of Chagas disease in dogs is important for veterinarian medicine. Trypanosoma cruzi infection is considered to be lifelong, with self-cure highly unlikely 2, 3 ; therefore, dogs with indirect fluorescent antibody (IFA) test immunoglobulin G (IgG) antibody titers are considered infected. 7, 8 In this study, dogs were counted as infected if their IFA IgG antibody titer was ≥20 or they had a histopathologic diagnosis of Chagas disease. The objective of this study was to report epidemiologic, cardiac troponin I (cTnI) and electrocardiographic characteristics, including the presence of arrhythmia or conduction abnormality and approximate anatomic origin of the abnormality within the heart, associated with T. cruzi infection status in dogs presenting to a teaching hospital in Texas. were considered significant. Odds ratios (ORs) and 95% confidence intervals were calculated for logistic regression models.
| MATERIALS AND METHODS
3 | RESULTS
| Study population
A total of 375 dogs had serological testing for anti-T. cruzi antibodies or T. cruzi-positive histology findings during the approximately 7-year study period. Dogs were considered to be infected if they had an IgG titer ≥20 or histologic evidence of T. cruzi. Of the 375 dogs, 63 (16.8%) were considered to be infected, including 59 which had a positive serology test result only and 4 with a histological diagnosis of Chagas disease. Of the 4 dogs with a histologic diagnosis, 1 had a negative IgG titer which is most likely a consequence of an acute infection and insufficient time for seroconversion. 35 Thirty dogs had multiple visits with repeat serological testing, including 20 with negative serology at both evaluations, 5 with positive titers at the first appointment and negative results at the second appointment (ie, seroreversion), and 5 with negative titers at the first appointment and positive titers at the second appointment (ie, seroconversion).
In the total population tested, age ranged from 0.2 to 16 years (median, 7.6 years; mean, 7.1 years), and 91 dog breeds were represented. The most common breeds tested were Labrador Retrievers (14.4%) and Boxers (10.6%). Negative dogs had a higher mean age (Table 1) . Breeds with less than 5 dogs total are grouped into "other." *Not all positive dogs had an ECG performed.
The most common AKC breed group tested was sporting dogs, which comprised 26% of the sampled dogs ( Table 2 ). The non-sporting breed group had the highest percentage of dogs that were infected (29%)
followed by the toy breed group (24%), although there were no statistically significant associations between breed group and T. cruzi infection status. The most frequent reason why dogs in the toy and non-sporting breed group were tested for T. cruzi was the presence of AV block (toy; 60%, non-sporting; 49%) and ventricular arrhythmias (toy; 33%, nonsporting; 31%). There were 207 males (55.2%) and 168 females (44.8%) tested with no difference in the proportion of infected dogs by sex (P = .69; Table 2 ).
Twelve dogs presented for evaluation from outside of Texas, whereas the remaining 363 dogs resided in 70 Texas counties spanning all ecoregions. 31 Infected dogs were from 33 counties and 8 ecoregions.
Bivariable analysis demonstrated a significant difference in infection status across ecoregion (P = .01), in which the highest proportion (47.4%) of infected dogs came from the South Texas Plains ecoregion followed by Edwards Plateau (31.6%; Table 2 ).
Between 2010 and 2016, 42 to 60 dogs per year had serological tests or histological findings of T. cruzi and the proportion of infected dogs varied across years from 5% to 27% (P = .04; Table 2 ). The odds of infection in dogs in the last 2 years of the study decreased and Table 2 ). In a linear regression analysis, the overall number of dogs tested did not vary significantly across year (P = .76).
T A B L E 2 Results of bivariable and logistic regression analysis of signalment, year of evaluation, and geographic location of residence for 375 dogs that received Trypanosoma cruzi serology testing or had T. cruzi histological findings between 2010 and 2016 
| Electrocardiographic and cardiac troponin I findings
Data assessed included ECG abnormalities and cTnI concentration. Electrocardiographic abnormalities were based on approximate anatomic location in the heart defined as (1) atria that includes sinus node, (2) AV node, or (3) ventricles and type of abnormality. In bivariable analysis, the T. cruzi infection status was not significantly associated (P = .73)
with the presence or absence of an ECG abnormality (Table 4) . Dogs with ECG abnormalities (N = 289) were analyzed using bivariable analysis as either having an abnormality at a specified anatomic location or not. For those dogs with abnormalities, infection with T. cruzi was significantly higher in dogs with an abnormality that originated from the ventricles (21.8%; P = .03; Table 4 ) than from the AV node or atria (11.3%). present (P = .006; Table 4 ). The odds of being infected were approximately 3 times greater (OR, 2.91; 95% CI, 1.37-5.99; P = .004) among dogs that had abnormalities at 2 or more anatomic locations than among dogs that had abnormalities at only 1 location. Only 1 T. cruzinegative dog had ECG abnormalities at all 3 anatomic locations. In bivariable analysis, significant association (P = .01) between T. cruzi infection status and the type of ECG abnormality (none, conduction, arrhythmia, or both) was found, with infection being the highest in dogs with both a conduction abnormality and arrhythmia (32%) and infection being the lowest in dogs having only a conduction abnormality (8.8%; The lowest range of cardiac troponin I was used as the referent in logistic regression. *Expected cell count in the contingency table <5, Fisher's exact test reported instead of chi square. † When dogs had abnormalities present at more than 1 location, it was counted in both locations.
T. cruzi-infected and T. cruzi-negative dogs with cTnI concentrations of 0.51-1.0 ng/mL and ≤0.5 ng/mL. 
| DISCUSSION
This study demonstrated that dogs infected with T. cruzi are found in all ecoregions in Texas and in many breed groups including breeds affected by well-described heart diseases that mimic Chagas disease. Trypanosoma cruzi infection has been found in over 48 different breeds in the United States with a high prevalence in the AKC sporting and working breed groups. 14, 36, 37 In this study, we found the highest prevalence in non-sporting (29%), toy (24%), and herding (21%) breed groups, and in multiple breeds with a predisposition for acquired heart diseases that result in a similar phenotype as Chagas cardiomyopathy.
For example, German Shepherds (30% positive in this population) that can develop breed-related inherited ventricular arrhythmias and sudden death at a very young age; Doberman Pinschers (25% positive) predisposed to idiopathic dilated cardiomyopathy characterized by cardiac enlargement, ventricular myocardial dysfunction, ventricular arrhythmias, CHF, and sudden death; and Bulldogs (54% positive) and Boxers (7% positive) that can develop arrhythmogenic right ventricular cardiomyopathy. [38] [39] [40] [41] This is an important point to consider when making a diagnosis of a heart disease that can mimic Chagas disease in a region known to have Chagas disease, as discrimination between Chagas disease and other etiologies of arrhythmias and ventricular systolic dysfunction could be difficult. Because T. cruzi infection is widespread and all breeds are at risk, it is important for veterinarians to consider T. cruzi testing in any dog when there is a clinical index of suspicion, including dogs with known risks for breed-related heart diseases.
Trypanosoma cruzi-positive dogs were reported from all 10 ecoregions present in Texas, demonstrating that T. cruzi is widespread across Texas.
Occurrence of T. cruzi infection in dogs in Texas is well documented in
the United States, and Texas could be a hotspot for infection with 7 triatomines capable of transmission, the highest nationwide. 2, 7, 8, 36, 37, [42] [43] [44] [45] [46] The high prevalence of dogs infected with T. cruzi likely demonstrates an established enzootic transmission cycle, as Texas harbors the highest species diversity of triatomine vectors that can transmit T. cruzi and a diversity of wildlife reservoirs. 2, 5, 47 The South Texas Plains ecoregion had the highest percent of infected dogs (47%), whereas the next highest region was the Edwards Plateau (32%). There is a greater than expected density of Triatoma gerstaeckeri in south central Texas, which is where we found the highest percent of infected dogs. 48 There is a significant difference between the percent of infection in triatomines collected from different ecoregions (P < .001), where triatomines collected from the Edwards Plateau had the highest infection prevalence of 65.0%
(n = 562). 47 The high density of infected vectors in these areas could increase exposure and infection in dogs. Furthermore, there is a high T. cruzi infection rate in dogs from south central Texas which includes the border with Mexico (this is the south Texas Plains ecoregion). 7, 8, 36, 43 In a population of dogs with T. cruzi testing from 1993 to 2007, more than 60% of the cases came from central and southern Texas. Mechanisms of myocardial damage in T. cruzi-infected dog and human patients include focal inflammation, diffuse fibrosis, edema, and scarring of the myocardium and conduction system. 35, 53, 54 This destruction can lead to a combination of arrhythmias, conduction disturbances, myocardial dysfunction, and heart failure in patients with Chagas disease.
Trypanosoma cruzi tissue tropism is primarily in the myocardium and can cause an inflammatory response that results in myocyte damage.
Cardiac troponin I is exclusively in cardiac myocytes and is released immediately after cardiac injury making it a sensitive and specific marker of myocardial injury. Cardiac troponin I is an indicator of myocardial damage, and increased cTnI concentrations occur in dogs and humans with Chagas cardiomyopathy. 35, 55 Serum cTnI levels slowly increase in infected dogs and spike at 10-30 mg/mL at approximately 21 days after infection. 56 Furthermore, cTnI serves as a rigorous biomarker because healthy individuals have negligible levels, and it circulates for days to weeks after cardiac injury 57 Regarding signalment as a risk factor for infection, T. cruzi in this population was widespread and not disproportionately associated with any breed group or sex. Older dogs have a higher prevalence of T. cruzi infection than younger dogs, likely because older dogs have had more opportunities for exposure. 5, 8, 14, 49 In our study population, infected dogs were significantly younger (mean = 5.9 years; P = .006) This study is limited in that it is retrospective and the quality of the data could vary, and in some cases, data was missing. Despite missing data for some variables, the sample sizes for each variable were relatively large and allowed for reliable statistical analysis (smallest sample size, n = 267). Furthermore, this study is limited in that the majority of dogs were referred to the hospital causing a selection bias. This limits the ability to apply the findings to the general dog population; however, this study still provides important insight into risk factors associated with T. cruzi infection. This study is further limited by being centered on dogs from Texas (n = 363); however, dogs from 8 other states were included, and Texas has a high prevalence of Chagas disease in dogs making it ideal for a retrospective study. 2 Other limitations include changes in the cTnI assay, from the Immulite 2000 with an analytical sensitivity of 0.2 ng/mL to the more sensitive ADVIA Centaur CP Ultra-TnI immunoassay which detects cTnI to 0.006 ng/mL. Due to the change in assay during the 7-year study, we analyzed the concentrations of cTnI separately, and the results cannot be directly compared between assays. One limitation to T. cruzi testing in dogs that there is no gold standard for diagnosis and discordant tests results are common. 8, 10 The use of multiple serology assays to determine positivity can be useful 7, 8, 37, [64] [65] [66] [67] and is in accordance with the WHO guidelines for human medicine. 68 Unfortunately, using multiple serology assays is not possible for veterinary medicine because the IFA is the only test approved for use in dogs. Therefore, the true infection rate in dogs is not known. Although other tests have been validated in dogs, they are not clinically available for diagnosis. 10 In contrast, human medicine relies on a suite of serology assays to determine if a patient is positive.
The ECG abnormalities reported here did not include 24-hour ambulatory ECG analysis which could improve detection of abnormalities.
Finally, detailed classification of echocardiographic abnormalities was not specifically assessed in this study because of the wide variety of diseases present in this population.
In summary, dogs infected with T. cruzi based on a titer ≥20 or histologic evidence were identified in all ecoregions in Texas and in a variety of breed groups. Dogs from breeds affected by well-described heart diseases that mimic Chagas heart disease can test positive for Chagas disease. The most common reasons for testing were an affected litter or housemate and the presence of cardiac abnormalities (CHF, ventricular enlargement with systolic dysfunction). Infected dogs were more likely to have ventricular arrhythmias and combinations of ECG abnormalities were commonly diagnosed. These findings suggest a need for an increased awareness of Chagas disease in dogs including the knowledge of when to consider testing for it.
